
M · NYSE
| FY2026 | FY2026 | FY2025 | FY2023 | FY2022 | FY2021 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $21.76B | $22.29B | $23.09B | $24.44B | $24.46B | $17.35B | $24.56B | $24.97B |
| Cost of Revenue | $13.50B | $13.74B | $14.22B | $15.35B | $14.97B | $12.29B | $15.17B | $15.21B |
| Selling, General & Administrative | $8.24B | $8.33B | $8.38B | $8.46B | $8.15B | $6.77B | $9.00B | $9.04B |
| Operating Income | $1.03B | $909.00M | $301.00M | $1.69B | $2.33B | -$4.47B | $970.00M | $1.74B |
| Interest Expense | $139.00M | $158.00M | $170.00M | $175.00M | $256.00M | $284.00M | $205.00M | $261.00M |
| Income Before Taxes | $849.00M | $763.00M | $43.00M | $1.48B | $1.85B | -$4.79B | $728.00M | $1.42B |
| Provision for Income Taxes | $207.00M | $181.00M | -$2.00M | $331.00M | $432.00M | -$846.00M | $164.00M | $322.00M |
| Net Income | $642.00M | $582.00M | $45.00M | $1.15B | $1.42B | -$3.94B | $564.00M | $1.11B |
| Basic EPS | $2.37 | $2.10 | $0.16 | $4.17 | $4.62 | -$12.68 | $1.82 | $3.60 |
| Diluted EPS | $2.32 | $2.07 | $0.16 | $4.08 | $4.52 | -$12.68 | $1.81 | $3.56 |
| Basic Shares Outstanding | 270.60M | 277.70M | 274.20M | 274.70M | 306.80M | 311.10M | 309.70M | 307.70M |
| Diluted Shares Outstanding | 276.50M | 281.60M | 278.20M | 281.10M | 314.00M | 311.10M | 311.40M | 311.40M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jan 2027 | $2.29 | $2.20 | $2.35 | 3 | ↑1 ↓0 |
| Jan 2028 | $2.36 | $2.19 | $2.54 | 5 | ↑1 ↓0 |
| Jan 2029 | $2.54 | $2.36 | $2.70 | 4 | ↑0 ↓0 |
| Jan 2030 | $2.56 | $2.56 | $2.56 | 1 | ↑0 ↓0 |